U.S. Markets closed

Fresenius Medical Care AG & Co. KGAA (FME.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
81.57-0.33 (-0.40%)
At close: 5:35PM CEST

Fresenius Medical Care AG & Co. KGAA

Else-Kröner Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
http://www.fmc-ag.com

SectorHealthcare
IndustryHospitals
Full Time Employees112,163

Key Executives

NameTitlePayExercisedAge
Mr. Robert Maurice Powell Jr.Chairman of the Mgmt Board - Fresenius Medical Care Mgmt AG & CEO of Fresenius Medical Care Mgmt AG4.6MN/A62
Mr. Michael BrosnanCFO of Fresenius Medical Care Mgmt AG & Member of the Mgmt Board - Fresenius Medical Care Mgmt AG2.99MN/A62
Mr. Kent WanzekCEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG2.13MN/A58
Dr. Olaf SchermeierCEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG1.58MN/A44
Mr. Dominik WehnerCEO-EMEA, Labor Relations Director-Germany & Member of Mgmt Board - Fresenius Medical Care Mgmt AG1.34MN/A48
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers laboratory services that include general testing, clinical anatomic pathology, and molecular testing. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2016, it operated 3,624 dialysis clinics in approximately 45 countries worldwide. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Corporate Governance

Fresenius Medical Care AG & Co. KGAA’s ISS Governance QualityScore as of September 1, 2017 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.